 <h1>Emgality Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>galcanezumab</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about galcanezumab. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Emgality.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to galcanezumab: subcutaneous solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, galcanezumab (the active ingredient contained in Emgality) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking galcanezumab:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Difficulty breathing</li>
<li>fast heartbeat</li>
<li>fever</li>
<li>hives, itching, skin rash</li>
<li>hoarseness</li>
<li>irritation</li>
<li>joint pain, stiffness, or swelling</li>
<li>redness of the skin</li>
<li>swelling of the eyelids, face, lips, hands, or feet</li>
<li>tightness in the chest</li>
<li>trouble with swallowing</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of galcanezumab may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site</li>
</ul><p>
<!-- end subcutaneous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to galcanezumab: subcutaneous solution</i></p><h3>General</h3><p>The most commonly reported adverse reaction has been injection site reactions.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity reactions (including dyspnea, urticaria, and rash)</p>
<p><b>Postmarketing reports</b>: Anaphylaxis, angioedema<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Anti-Drug-Antibodies (up to 12.5%)<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site reactions (18%)<sup>[Ref]</sup></p><p>Injection site reaction included event terms such as injection site pain, injection site reaction, injection site erythema, and injection site pruritus.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Vertigo</p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus</p>
<p><b>Uncommon</b> (0.1% to 1%): Urticaria</p>
<p><b>Postmarketing reports</b>: Rash</p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Emgality (galcanezumab)." Lilly, Eli and Company, Indianapolis, IN. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Does it cause weight gain?</li>
<li>How long does it take to work?</li>
<li>Do the injections hurt?</li>
<li>How does it work?</li>
<li>Emgality vs Aimovig - how do they compare?</li>
<li>What are the new drugs for the treatment and prevention of migraine?</li>
<li>Ubrelvy vs Emgality: How do they compare for migraines?</li>
<li>What is the cost of the migraine drug Ajovy?</li>
<li>What type of drug is Ajovy?</li>
<li>What type of drug is Emgality?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Emgality (galcanezumab)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>253 Reviews</li>
<li>Drug class: CGRP inhibitors</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Emgality &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Cluster Headaches</li>
<li>Migraine Prevention</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to galcanezumab: subcutaneous solution</i></p><h3>General</h3><p>The most commonly reported adverse reaction has been injection site reactions.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity reactions (including dyspnea, urticaria, and rash)</p><p><b>Postmarketing reports</b>: Anaphylaxis, angioedema<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Anti-Drug-Antibodies (up to 12.5%)<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site reactions (18%)<sup>[Ref]</sup></p><p>Injection site reaction included event terms such as injection site pain, injection site reaction, injection site erythema, and injection site pruritus.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Vertigo</p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus</p><p><b>Uncommon</b> (0.1% to 1%): Urticaria</p><p><b>Postmarketing reports</b>: Rash</p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation</p><p id="ref_1">1. "Product Information. Emgality (galcanezumab)." Lilly, Eli and Company, Indianapolis, IN. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Does it cause weight gain?</li>
<li>How long does it take to work?</li>
<li>Do the injections hurt?</li>
<li>How does it work?</li>
<li>Emgality vs Aimovig - how do they compare?</li>
<li>What are the new drugs for the treatment and prevention of migraine?</li>
<li>Ubrelvy vs Emgality: How do they compare for migraines?</li>
<li>What is the cost of the migraine drug Ajovy?</li>
<li>What type of drug is Ajovy?</li>
<li>What type of drug is Emgality?</li>
</ul><h2>More about Emgality (galcanezumab)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>253 Reviews</li>
<li>Drug class: CGRP inhibitors</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Emgality &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Cluster Headaches</li>
<li>Migraine Prevention</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>